Disease/Infection News

RSS

Hexavalent vaccine can reduce spread of whooping cough

Comprehensive coverage of the hexavalent vaccine can protect against whooping cough and polio, averting disease resurgence, writes Esther Nakkazi.

7 Nov 2024

Could vitamin D help COVID-19 patients? Meta-analysis highlights potential ICU reduction

Vitamin D may lower ICU and intubation rates in COVID-19 patients, with significant benefits observed in older and severe cases, according to recent research.

7 Nov 2024

How bacteria trigger colon cancer

Investigation shows how bacterial adhesins contribute to colon cancer mutations, suggesting new avenues for therapeutic intervention in colorectal cancer.

7 Nov 2024

Anti-inflammatory cytokine linked to capillary obstruction and cognitive decline in diabetes

Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.

7 Nov 2024

Leritrelvir shows high efficacy against SARS-CoV-2 protease mutations

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.

6 Nov 2024

Emerging therapies transform autoimmune hepatitis treatment approaches

Autoimmune hepatitis (AIH) is a chronic, progressive liver disease caused by immune system dysregulation that targets the liver. If untreated, AIH can lead to severe complications, including cirrhosis and liver failure.

6 Nov 2024

Unraveling the psychological impact of COVID-19 on young minds

The COVID-19 pandemic, which began in late 2019, brought immense disruption to individuals and societies worldwide, including children and adolescents. Alongside its immediate physical health impacts, the pandemic had a profound effect on mental health.

6 Nov 2024

Study links nasal autoantibodies to COVID-19 severity prediction

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially greater risk of severe disease.

6 Nov 2024

WHO report highlights surge in TB cases and deaths in 2023

The highest number of tuberculosis (TB) cases since global monitoring began were recorded in 2023, according to a report published by the World Health Organization (WHO).

6 Nov 2024

Saturated fats accelerate neurodegeneration in multiple sclerosis

Targeting ceramide synthase enzymes may reduce multiple sclerosis severity by limiting ceramide C16 synthesis, offering potential neuroprotective strategies.

6 Nov 2024

Solascure and U.S. Army Institute of Surgical Research collaborate for combat wound care

SOLASCURE Ltd ("SolasCure"), a biotechnology company developing a novel treatment to transform chronic wound care and the U.S. Army Institute of Surgical Research ("USAISR"), today announced a research collaboration to evaluate SolasCure's investigational product, Aurase Wound Gel, as a means for managing combat wounds.

From SolasCure 6 Nov 2024

Sleep apnea raises dementia risk in older women

Researchers determine the differential risk of dementia among men and women based on the presence of obstructive sleep apnea.

6 Nov 2024

Targeted bacteriophages offer standardized and scalable GI therapy

In a new study, researchers at the University of Copenhagen have been cultivating 'good viruses' from feces. The goal is to replace fecal capsules now being used in so-called fecal transplants. Their new technique has shown potential in studies with mice and the hope is that it will improve this life-saving treatment through standardization and pave its way toward mainstream medicine.

5 Nov 2024

WHO study names top pathogens in need of new vaccines

A new World Health Organization (WHO) study published today in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development.

5 Nov 2024

Study finds high risk of pediatric tuberculosis in high-burden areas

New findings also indicate that children who live in settings with a high burden of TB have a consistently high annual risk of developing TB infection throughout childhood.

5 Nov 2024

Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis

Researchers identified a unique antibody signature against the Epstein-Barr virus protein EBNA1 that correlates with cross-reactive immune responses in multiple sclerosis (MS) patients. This connection provides new insights into how EBV infection may drive MS pathogenesis.

5 Nov 2024